SIGLEC15 and bladder transitional cell carcinoma: Furthermore, we demonstrated that the expression of Siglec15 was mutually exclusive of several immune checkpoints, including PD-L1, PD-1, CTLA-4, and LAG-3 in BLCA (Figure 2B-E, Table S2).